- Home
- AIOS vs MIRA Comparison
AIOS vs MIRA Comparison
Compare AIOS & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AIOS | MIRA |
|---|---|---|
| Founded | 2005 | 2020 |
| Country | China | United States |
| Employees | 20 | N/A |
| Industry | Metal Fabrications | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 44.3M | 37.1M |
| IPO Year | N/A | 2023 |
Fundamental Metrics
Financial Performance| Metric | AIOS | MIRA |
|---|---|---|
| Price | $11.80 | $0.79 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 18.6K | ★ 52.6K |
| Earning Date | 04-20-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.39 | $0.80 |
| 52 Week High | $33.87 | $2.45 |
Technical Indicators
Market Signals| Indicator | AIOS | MIRA |
|---|---|---|
| Relative Strength Index (RSI) | 44.03 | 31.94 |
| Support Level | $10.45 | N/A |
| Resistance Level | $16.24 | $1.02 |
| Average True Range (ATR) | 1.26 | 0.06 |
| MACD | -0.10 | -0.01 |
| Stochastic Oscillator | 40.30 | 8.80 |
Price Performance
Historical ComparisonAbout AIOS AIOS Tech Inc. Class A Common Shares
AIOS Tech Inc is a provider of artificial intelligence and technology-driven professional services. The Company is focused on delivering information technology solutions, data services, and artificial intelligence-powered offerings to a diverse commercial client base. Its core businesses include digital transformation services, tailored IT solutions for the financial sector, enterprise data solutions, and the development of AI platforms and infrastructure to drive efficiency and growth for clients across multiple industries.
About MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a clinical-stage pharmaceutical development company focused on developing novel oral small-molecule therapeutics for neurologic, neuropsychiatric, metabolic, and inflammatory disorders. The company's pipeline includes three product candidates: Ketamir-2, MIRA-55, and SKNY-1, three drug candidates designed to address unmet medical needs across neuropathic and inflammatory pain, central nervous system disorders, and metabolic and behavioral conditions. The company operates as a single operating and reportable segment.